Clover Health Investments, Corp.
CLOV
$2.00
-$0.07-3.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.41% | 1.98% | |||
| Total Other Revenue | -89.03% | 114.55% | |||
| Total Revenue | -1.64% | 3.82% | |||
| Cost of Revenue | -2.36% | 12.03% | |||
| Gross Profit | 2.53% | -27.35% | |||
| SG&A Expenses | 26.72% | -11.52% | |||
| Depreciation & Amortization | 3.45% | 3.05% | |||
| Other Operating Expenses | 100.00% | -- | |||
| Total Operating Expenses | 3.23% | 6.56% | |||
| Operating Income | -102.32% | -130.86% | |||
| Income Before Tax | -102.32% | -130.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -102.32% | -130.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -102.32% | -130.45% | |||
| EBIT | -102.32% | -130.86% | |||
| EBITDA | -103.99% | -135.82% | |||
| EPS Basic | -100.84% | -128.37% | |||
| Normalized Basic EPS | -100.67% | -128.46% | |||
| EPS Diluted | -100.84% | -128.37% | |||
| Normalized Diluted EPS | -100.67% | -128.46% | |||
| Average Basic Shares Outstanding | 0.88% | 0.73% | |||
| Average Diluted Shares Outstanding | 0.88% | 0.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||